One-year outcomes of prenatal exposure to MDMA and other recreational drugs

Pediatrics

Volumn 130, Issue 3, 2012, Pages 407-413

  Singer, Lynn T ^a   Moore, Derek G ^b   Min, Meeyoung O ^a   Goodwin, Julia ^b   Turner, John J D ^b   Fulton, Sarah ^a   Parrott, Andrew C ^c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF EAST LONDON   (United Kingdom)

^c SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

3,4 Methylenedioxymethamphetamine; Drugs; Ecstasy; Infant development; MDMA; Motor skills; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMPHETAMINE; CANNABIS; CIGARETTE SMOKE; COCAINE; KETAMINE; LYSERGIDE; OPIATE; TRANQUILIZER;

ARTICLE; CHILD; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DEVELOPMENTAL TOXICITY; DOSE RESPONSE; DRUG USE; EDUCATIONAL STATUS; EMOTION; FEMALE; HUMAN; INFANT; LANGUAGE DEVELOPMENT; MAJOR CLINICAL STUDY; MALE; MENTAL DEVELOPMENT; MOTOR DEVELOPMENT; NEUROTOXICITY; OUTCOME ASSESSMENT; PARENTAL STRESS; PREGNANCY; PRENATAL DRUG EXPOSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SOCIAL CLASS;

COGNITION; DEVELOPMENTAL DISABILITIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HALLUCINOGENS; HUMANS; INFANT; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHOMOTOR PERFORMANCE; SOCIOECONOMIC FACTORS;

EID: 84865791863     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-0666     Document Type: Article

References (30)

1. Johnston LD, O'Mally PM, Brachman JG, Schulenberg JF. Monitoring the Future: national survey results on drug use, 1975-2004: College students and adults ages 19-45. Bethesda, MD: National Institute on Drug Abuse; 2005.
2. Parrott AC, Lock J, Conner AC, Kissling C, Thome J. Dance clubbing on MDMA and during abstinence from Ecstasy/MDMA: prospective neuroendocrine and psychobiological changes. Neuropsychobiology. 2008;57(4):165-180
3. Rudnick G, Wall SC. The molecular mechanism of "ecstasy" [3,4-methylenedioxymethamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc Natl Acad Sci U S A. 1992;89(5):1817-1821
4. Parrott AC. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress. J Psychopharmacol. 2006;20(2):147-163
5. Kish SJ, Lerch J, Furukawa Y, et al. Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study. Brain. 2010;133(pt 6):1779-1797
6. Turner JJD, Nicolas L, Parrott AC. Reduced calorie intake in the week following weekend MDMA (ecstasy) use. J Psychopharmacol. 1998;12:a43
7. Skelton MR, Williams MT, Vorhees CV. Developmental effects of 3,4-methylenedioxymethamphetamine: a review. Behav Pharmacol. 2008;19(2):91-111
8. Vorhees CV, Schaefer TL, Skelton MR, Grace CE, Herring NR, Williams MT. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) dose-dependently impairs spatial learning in the Morris water maze after exposure of rats to different five-day intervals from birth to postnatal day twenty. Dev Neurosci. 2009;31(1-2):107-120
9. Koprich JB, Chen EY, Kanaan NM, Campbell NG, Kordower JH, Lipton JW. Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats. Neurotoxicol Teratol. 2003;25(5):509-517
10. Thompson VB, Heiman J, Chambers JB, et al. Long-term behavioral consequences of prenatal MDMA exposure. Physiol Behav. 2009;96(4-5):593-601
11. Thompson VB, Koprich JB, Chen EY, Kordower JH, Terpstra BT, Lipton JW. Prenatal exposure to MDMA alters noradrenergic neurodevelopment in the rat. Neurotoxicol Teratol. 2012;34(1):206-213
12. van Tonningen-van Driel MM, Garbis-Berkvens JM, Reuvers-Lodewijks WE. Pregnancy outcome after ecstasy use; 43 cases followed by the Teratology Information Service of the National Institute for Public Health and Environment (RIVM) [in Dutch]. Ned Tijdschr Geneeskd. 1999;143(1):27-31
13. McElhatton PR, Bateman DN, Evans C, Pughe KR, Thomas SH. Congenital anomalies after prenatal ecstasy exposure. Lancet. 1999;354(9188):1441-1442
14. Singer LT, Moore DG, Fulton S, et al. Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy. Neurotoxicol Teratol. 2012;34(3):303-310
15. Moore DG, Turner JJT, Parrott AC, et al. During pregnancy, recreational drug-using women stop taking ecstasy (MDMA) and reduce alcohol consumption but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study. J Psychopharmacol. 2010;24(9):1403-1410
16. Moore DG, Turner JJD, Goodwin JE, Fulton SE, Singer LT, Parrott AC. In-utero exposure to the popular 'recreational' drugs MDMA (Ecstasy) and Methamphetamine (Ice, crystal): preliminary findings. In: Preece P, Riley E, eds. Alcohol, Drugs and Medication in Pregnancy: The Long Term Outcome for the Child. London, England: Mac Keith Press; 2011:169-182
17. Singer LT, Arendt R, Minnes S, et al. Cognitive and motor outcomes of cocaine-exposed infants. JAMA. 2002;287(15):1952-1960
18. Parrott AC, Milani R, Parmar R, Turner JJD. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems. Psychopharmacology (Berl). 2001;159(1):77-82
19. Skinner HA. The drug abuse screening test. Addict Behav. 1982;7(4):363-371
20. Derogatis LR. The Brief Symptom Inventory Manual (BSI). Baltimore, MD: Clinical Psychometric Research; 1992
21. Wechsler D. Wechsler Abbreviated Scale of Intelligence (WASI). San Antonio, TX: Harcourt Assessment; 1999
22. Abidin RR. Parenting Stress Index. 2nd ed. Charlottesville, VA: Pediatric Psychology Press; 1986
23. Caldwell B, Bradley R. Home Observation for Measurement of the Environment. Little Rock, AR: University of Arkansas; 1984
24. Bayley N. Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III). San Antonio, TX: The Psychological Corporation; 2005
25. Zimmerman IL, Steiner VG, Pond RE. PLS-3: Preschool Language Scale-3. San Antonio, TX: The Psychological Corporation; 1992
26. Powell CM, Michaelis RC. Townes-Brocks syndrome. J Med Genet. 1999;36(2):89-93
27. Azmitia EC. Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis. Brain Res Bull. 2001;56(5):413-424
28. Cohen MA, Skelton MR, Schaefer TL, Gudelsky GA, Vorhees CV, Williams MT. Learning and memory after neonatal exposure to 3,4-methylenedioxymethamphetamine (ecstasy) in rats: interaction with exposure in adulthood. Synapse. 2005;57(3):148-159
29. Broening HW, Morford LL, Inman-Wood SL, Fukumura M, Vorhees CV. 3,4-methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development. J Neurosci. 2001;21(9):3228-3235
30. Vorhees CV, Reed TM, Skelton MR, Williams MT. Exposure to 3,4-methylenedioxymethamphetamine (MDMA) on postnatal days 11-20 induces reference but not working memory deficits in the Morris water maze in rats: implications of prior learning. Int J Dev Neurosci. 2004;22(5-6):247-259